Lead Product(s): Rexlemestrocel-L,Hyaluronic Acid
Therapeutic Area: Neurology Product Name: MPC-06-ID
Highest Development Status: Phase III Product Type: Cell and Gene therapy
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable February 10, 2021
A single injection of rexlemestrocel-L may provide a durable, and effective opioid-sparing therapy for patients with chronic inflammatory back pain due to degenerative disc disease. Greatest benefits were seen when administered earlier in the disease process.